Orbimed Advisors LLC, Director, 10% Owner at Corvus Pharmaceuticals, Inc. (CRVS), sold 2,352,664 shares at $4.16 ($9.8M) on 2025-06-27, disclosed to the SEC on 2025-07-01.
Open-market sale of $9.8M CRVS by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.16 | 1,176,332 | $4.9M | 50.0% |
| 2 | $4.16 | 1,176,332 | $4.9M | 50.0% |
| Total | $4.16 avg | 2,352,664 | $9.8M | 100% |
| Filing → |
| BRVE | BUY | 2026-08-11 | $34.9M | — | Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| SION | SELL | 2026-07-09 | $3.9M | — | Filing → |